A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling

Claire E. Wakefield; Bettina Meiser; Judi Homewood; Alan Taylor; Margaret Gleeson; Rachel Williams; Kathy Tucker; K. Barlow-Stewart; G. Fenton; A. Goodwin; J. Kirk; P. Zodgekar; L. Andrews; J. Koehler; A. Overkov; M. Peate; J. Tyler; B. Warner; T. Dudding; C. Groombridge; S. O'Donnell; A. Spigelman; C. McMahon; L. Hossack; M. Kentwell; M. Young; C. Aragona; R. D'Souza; C. Gaff; L. Hodgkin; R. Ward; P. Butow; E. Lobb

doi:10.1002/pon.1353

A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling

Claire E. Wakefield^*, Bettina Meiser, Judi Homewood, Alan Taylor, Margaret Gleeson, Rachel Williams, Kathy Tucker, K. Barlow-Stewart, G. Fenton, A. Goodwin, J. Kirk, P. Zodgekar, L. Andrews, J. Koehler, A. Overkov, M. Peate, J. Tyler, B. Warner, T. Dudding, C. Groombridge & 13 others S. O'Donnell, A. Spigelman, C. McMahon, L. Hossack, M. Kentwell, M. Young, C. Aragona, R. D'Souza, C. Gaff, L. Hodgkin, R. Ward, P. Butow, E. Lobb

^*Corresponding author for this work

Research output: Contribution to journal › Article

32 Citations (Scopus)

Abstract

Objectives: To evaluate the impact of a decision aid for women considering genetic testing for breast/ovarian cancer risk given during genetic counseling. Methods: One hundred and forty-eight women were randomized to receive the decision aid or a control pamphlet at the beginning of their first consultation with a genetic counselor. When the patient received the decision aid, it was used to complement consultation discussions about genetic testing. One hundred and ten (74.3%) women completed the first questionnaire designed to elicit information about women's levels of decisional conflict and knowledge about genetic testing. Of these, 105 (70.9%) completed a second questionnaire to assess longer-term outcomes, 6 months postconsultation. Results: Results showed that women who received the decision aid felt more informed about genetic testing (χ²(1) = 8.69; P = 0.003), had clearer values (χ²(1) = 6.90; P = 0.009) and had higher knowledge levels (χ²(2) = 6.49; P = 0.039) than women who received the control pamphlet. Conclusions: The developed decision aid improved patient outcomes better than a control pamphlet when implemented during genetic counseling and given to the patient to take home.

Original language	English
Pages (from-to)	844-854
Number of pages	11
Journal	Psycho-Oncology
Volume	17
Issue number	8
DOIs	https://doi.org/10.1002/pon.1353
Publication status	Published - Aug 2008

Access to Document

10.1002/pon.1353

Link to publication in Scopus

Fingerprint Dive into the research topics of 'A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling'. Together they form a unique fingerprint.

Cite this

Wakefield, Claire E. ; Meiser, Bettina ; Homewood, Judi ; Taylor, Alan ; Gleeson, Margaret ; Williams, Rachel ; Tucker, Kathy ; Barlow-Stewart, K. ; Fenton, G. ; Goodwin, A. ; Kirk, J. ; Zodgekar, P. ; Andrews, L. ; Koehler, J. ; Overkov, A. ; Peate, M. ; Tyler, J. ; Warner, B. ; Dudding, T. ; Groombridge, C. ; O'Donnell, S. ; Spigelman, A. ; McMahon, C. ; Hossack, L. ; Kentwell, M. ; Young, M. ; Aragona, C. ; D'Souza, R. ; Gaff, C. ; Hodgkin, L. ; Ward, R. ; Butow, P. ; Lobb, E. / A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. In: Psycho-Oncology. 2008 ; Vol. 17, No. 8. pp. 844-854.

@article{f7c88672a73c4102895b288d471ae453,

title = "A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling",

abstract = "Objectives: To evaluate the impact of a decision aid for women considering genetic testing for breast/ovarian cancer risk given during genetic counseling. Methods: One hundred and forty-eight women were randomized to receive the decision aid or a control pamphlet at the beginning of their first consultation with a genetic counselor. When the patient received the decision aid, it was used to complement consultation discussions about genetic testing. One hundred and ten (74.3{\%}) women completed the first questionnaire designed to elicit information about women's levels of decisional conflict and knowledge about genetic testing. Of these, 105 (70.9{\%}) completed a second questionnaire to assess longer-term outcomes, 6 months postconsultation. Results: Results showed that women who received the decision aid felt more informed about genetic testing (χ2(1) = 8.69; P = 0.003), had clearer values (χ2(1) = 6.90; P = 0.009) and had higher knowledge levels (χ2(2) = 6.49; P = 0.039) than women who received the control pamphlet. Conclusions: The developed decision aid improved patient outcomes better than a control pamphlet when implemented during genetic counseling and given to the patient to take home.",

author = "Wakefield, {Claire E.} and Bettina Meiser and Judi Homewood and Alan Taylor and Margaret Gleeson and Rachel Williams and Kathy Tucker and K. Barlow-Stewart and G. Fenton and A. Goodwin and J. Kirk and P. Zodgekar and L. Andrews and J. Koehler and A. Overkov and M. Peate and J. Tyler and B. Warner and T. Dudding and C. Groombridge and S. O'Donnell and A. Spigelman and C. McMahon and L. Hossack and M. Kentwell and M. Young and C. Aragona and R. D'Souza and C. Gaff and L. Hodgkin and R. Ward and P. Butow and E. Lobb",

year = "2008",

month = "8",

doi = "10.1002/pon.1353",

language = "English",

volume = "17",

pages = "844--854",

journal = "Psycho‐Oncology",

issn = "1057-9249",

publisher = "John Wiley & Sons",

number = "8",

}

Wakefield, CE, Meiser, B, Homewood, J, Taylor, A, Gleeson, M, Williams, R, Tucker, K, Barlow-Stewart, K, Fenton, G, Goodwin, A, Kirk, J, Zodgekar, P, Andrews, L, Koehler, J, Overkov, A, Peate, M, Tyler, J, Warner, B, Dudding, T, Groombridge, C, O'Donnell, S, Spigelman, A, McMahon, C, Hossack, L, Kentwell, M, Young, M, Aragona, C, D'Souza, R, Gaff, C, Hodgkin, L, Ward, R, Butow, P & Lobb, E 2008, 'A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling', Psycho-Oncology, vol. 17, no. 8, pp. 844-854. https://doi.org/10.1002/pon.1353

A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. / Wakefield, Claire E.; Meiser, Bettina; Homewood, Judi; Taylor, Alan; Gleeson, Margaret; Williams, Rachel; Tucker, Kathy; Barlow-Stewart, K.; Fenton, G.; Goodwin, A.; Kirk, J.; Zodgekar, P.; Andrews, L.; Koehler, J.; Overkov, A.; Peate, M.; Tyler, J.; Warner, B.; Dudding, T.; Groombridge, C.; O'Donnell, S.; Spigelman, A.; McMahon, C.; Hossack, L.; Kentwell, M.; Young, M.; Aragona, C.; D'Souza, R.; Gaff, C.; Hodgkin, L.; Ward, R.; Butow, P.; Lobb, E.

In: Psycho-Oncology, Vol. 17, No. 8, 08.2008, p. 844-854.

Research output: Contribution to journal › Article

TY - JOUR

T1 - A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling

AU - Wakefield, Claire E.

AU - Meiser, Bettina

AU - Homewood, Judi

AU - Taylor, Alan

AU - Gleeson, Margaret

AU - Williams, Rachel

AU - Tucker, Kathy

AU - Barlow-Stewart, K.

AU - Fenton, G.

AU - Goodwin, A.

AU - Kirk, J.

AU - Zodgekar, P.

AU - Andrews, L.

AU - Koehler, J.

AU - Overkov, A.

AU - Peate, M.

AU - Tyler, J.

AU - Warner, B.

AU - Dudding, T.

AU - Groombridge, C.

AU - O'Donnell, S.

AU - Spigelman, A.

AU - McMahon, C.

AU - Hossack, L.

AU - Kentwell, M.

AU - Young, M.

AU - Aragona, C.

AU - D'Souza, R.

AU - Gaff, C.

AU - Hodgkin, L.

AU - Ward, R.

AU - Butow, P.

AU - Lobb, E.

PY - 2008/8

Y1 - 2008/8

N2 - Objectives: To evaluate the impact of a decision aid for women considering genetic testing for breast/ovarian cancer risk given during genetic counseling. Methods: One hundred and forty-eight women were randomized to receive the decision aid or a control pamphlet at the beginning of their first consultation with a genetic counselor. When the patient received the decision aid, it was used to complement consultation discussions about genetic testing. One hundred and ten (74.3%) women completed the first questionnaire designed to elicit information about women's levels of decisional conflict and knowledge about genetic testing. Of these, 105 (70.9%) completed a second questionnaire to assess longer-term outcomes, 6 months postconsultation. Results: Results showed that women who received the decision aid felt more informed about genetic testing (χ2(1) = 8.69; P = 0.003), had clearer values (χ2(1) = 6.90; P = 0.009) and had higher knowledge levels (χ2(2) = 6.49; P = 0.039) than women who received the control pamphlet. Conclusions: The developed decision aid improved patient outcomes better than a control pamphlet when implemented during genetic counseling and given to the patient to take home.

AB - Objectives: To evaluate the impact of a decision aid for women considering genetic testing for breast/ovarian cancer risk given during genetic counseling. Methods: One hundred and forty-eight women were randomized to receive the decision aid or a control pamphlet at the beginning of their first consultation with a genetic counselor. When the patient received the decision aid, it was used to complement consultation discussions about genetic testing. One hundred and ten (74.3%) women completed the first questionnaire designed to elicit information about women's levels of decisional conflict and knowledge about genetic testing. Of these, 105 (70.9%) completed a second questionnaire to assess longer-term outcomes, 6 months postconsultation. Results: Results showed that women who received the decision aid felt more informed about genetic testing (χ2(1) = 8.69; P = 0.003), had clearer values (χ2(1) = 6.90; P = 0.009) and had higher knowledge levels (χ2(2) = 6.49; P = 0.039) than women who received the control pamphlet. Conclusions: The developed decision aid improved patient outcomes better than a control pamphlet when implemented during genetic counseling and given to the patient to take home.

UR - http://www.scopus.com/inward/record.url?scp=51649083576&partnerID=8YFLogxK

U2 - 10.1002/pon.1353

DO - 10.1002/pon.1353

M3 - Article

VL - 17

SP - 844

EP - 854

JO - Psycho‐Oncology

JF - Psycho‐Oncology

SN - 1057-9249

IS - 8

ER -